Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Shlofmitz

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
JACC. Cardiovascular Interventions|November 26, 2025
Paclitaxel-Coated Balloon for the Treatment of Small Vessel In-Stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized TrialJason Wen, Suhail Dohad, Richard Shlofmitz, et al.
Journal of the American Heart Association|January 19, 2026
Paclitaxel-Coated Balloon for Treating In-Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE TrialYasser Jamil, Ajay Kirtane, Robert W Yeh, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 3, 2022
Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registryJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 10, 2020
Orbital Atherectomy for Treatment of Severely Calcified Coronary Artery Bifurcation Lesions: A Multicenter AnalysisRobert Sturm, Ehrin J Armstrong, Benjamin Benhuri, et al.
European Heart Journal|May 19, 2023
Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR groupEmanuele Barbato, Emanuele Gallinoro, Mohamed Abdel-Wahab, et al.
Journal of the American College of Cardiology|August 13, 2025
Paclitaxel-Coated Balloon for the Treatment of Multilayer In-Stent Restenosis: AGENT IDE Subgroup AnalysisAjay J Kirtane, Richard Shlofmitz, Jeffrey Moses, et al.
Journal of the American College of Cardiology|April 3, 2020
Ticagrelor With or Without Aspirin After Complex PCIGeorge Dangas, Usman Baber, Samin Sharma, et al.
Circulation|July 6, 2026
Paclitaxel-Coated Balloon Versus Uncoated Balloon for Coronary In-Stent Restenosis: Two-Year Follow-Up of the AGENT-IDE Randomized Clinical TrialJeffrey Moses, Jiho Han, Richard Shlofmitz, et al.
JAMA|March 9, 2024
Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical TrialRobert W Yeh, Richard Shlofmitz, Jeffrey Moses, et al.
European Heart Journal|October 18, 2021
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBRJavier Escaned, Davide Cao, Usman Baber, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
JACC. Cardiovascular Interventions|November 26, 2025
Paclitaxel-Coated Balloon for the Treatment of Small Vessel In-Stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized TrialJason Wen, Suhail Dohad, Richard Shlofmitz, et al.
Journal of the American Heart Association|January 19, 2026
Paclitaxel-Coated Balloon for Treating In-Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE TrialYasser Jamil, Ajay Kirtane, Robert W Yeh, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 3, 2022
Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registryJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 10, 2020
Orbital Atherectomy for Treatment of Severely Calcified Coronary Artery Bifurcation Lesions: A Multicenter AnalysisRobert Sturm, Ehrin J Armstrong, Benjamin Benhuri, et al.
European Heart Journal|May 19, 2023
Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR groupEmanuele Barbato, Emanuele Gallinoro, Mohamed Abdel-Wahab, et al.
Journal of the American College of Cardiology|August 13, 2025
Paclitaxel-Coated Balloon for the Treatment of Multilayer In-Stent Restenosis: AGENT IDE Subgroup AnalysisAjay J Kirtane, Richard Shlofmitz, Jeffrey Moses, et al.
Journal of the American College of Cardiology|April 3, 2020
Ticagrelor With or Without Aspirin After Complex PCIGeorge Dangas, Usman Baber, Samin Sharma, et al.
Circulation|July 6, 2026
Paclitaxel-Coated Balloon Versus Uncoated Balloon for Coronary In-Stent Restenosis: Two-Year Follow-Up of the AGENT-IDE Randomized Clinical TrialJeffrey Moses, Jiho Han, Richard Shlofmitz, et al.
JAMA|March 9, 2024
Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical TrialRobert W Yeh, Richard Shlofmitz, Jeffrey Moses, et al.
European Heart Journal|October 18, 2021
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBRJavier Escaned, Davide Cao, Usman Baber, et al.
Pageof 8